Financial News
Aytu Biopharma Inc (NQ: AYTU )
2.440
-0.030
(-1.21%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Aytu Biopharma Inc
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_1069.jpeg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
Aytu BioPharma Appoints Mark Oki as Chief Financial Officer
January 04, 2022
From Aytu BioPharma, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
Aytu BioPharma to Present at H.C. Wainwright BioConnect Conference
January 03, 2022
From Aytu BioPharma, Inc.
Via AccessWire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_6058.jpeg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
Aytu BioPharma Ranked Number 178 Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 50(TM)
November 17, 2021
From Aytu BioPharma, Inc.
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
Aytu BioPharma Reports First Quarter 2022 Financial Results
November 15, 2021
From Aytu BioPharma, Inc.
Via AccessWire
Topics
Regulatory Compliance
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech_4.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_98.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_378.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-2815640_1920_1_12.jpg)
Via Benzinga
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png)
From Aytu BioPharma, Inc.
Via AccessWire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_96.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_25.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_2135.jpeg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png)
Aytu BioPharma Reports Fourth Quarter and Full-Year Fiscal 2021 Financial Results
September 27, 2021
From Aytu BioPharma, Inc.
Via AccessWire
Topics
Regulatory Compliance
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_22.jpeg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medic-563423_1920_398_58.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_93.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_374.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_373.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.